Comparing Prophylactic Vaginal Progesterone & Cervical Cerclage In Preventing Preterm Birth: A Systematic Review


  • Saman Ejaz King Edward Medical University, 54000, Lahore Punjab Pakistan
  • Maryam Raana King Edward Medical University, 54000, Lahore Punjab Pakistan
  • Muhammad Essa King Edward Medical University, Lahore
  • Sadaf Zahra King Edward Medical University, 54000, Lahore Punjab Pakistan
  • Snovia Ishaq King Edward Medical University, 54000, Lahore Punjab Pakistan
  • Uswa Shoaib King Edward Medical University, 54000, Lahore Punjab Pakistan
  • Muhammad Irshad Department of Zoology, Ghazi University, DG Khan, Pakistan.
  • Zain Ul Abideen Institute of Zoology, Bahauddin Zakariyya University, Multan, Pakistan



Preterm birth;, Prophylactic Vaginal Progesterone, Cervical Cerclag, pregnancy


Preterm birth complicates at-risk singleton pregnancies, and this is associated with a poor prognosis for pregnant mothers. When comparing cervical cerclage to vaginal progesterone, the rationale is clear, but its effectiveness remains a mystery.It is the goal of this systematic review to shed further light on this well-known conundrum. To find research on preventive vaginal progesterone usage vs cervical cerclage, PubMed, PubMed Central, Medline, Science Direct, and Google Scholar were searched. There were three randomized control trials, three systematic reviews and meta-analyses, two cohort studies, and two conventional reviews. It was determined that both strategies for managing preterm delivery were equally effective in terms of preterm birth prevention when applied to pregnant women. We found that vaginal progesterone had less side effects than cervical cerclage, but it has no influence on a woman's ability to function and does not improve her life expectancy. The systematic reviews and randomized controlled studies unequivocally confirmed these findings. Cervical cerclage was shown to be more risky than preventive vaginal progesterone in a comprehensive study. However, prophylactic application of cervical cerclage still remains a superior treatment modality if serial transvaginal ultrasound scans are pointing towards cervical shortening. Therefore, more research is required to understand this relationship to identify populations at risk.


Chaman-Ara, K., et al., Progesterone therapy for the prevention of preterm labor in women with single risk-factor: a systematic review and meta-analysis. Bali Medical Journal, 2016. 5(1): p. 38-44.

Mwaniki, M.K., et al., Long-term neurodevelopmental outcomes after intrauterine and neonatal insults: a systematic review. The Lancet, 2012. 379(9814): p. 445-452.

Khasawneh, W. and W. Khriesat, Assessment and comparison of mortality and short-term outcomes among premature infants before and after 32-week gestation: A cross-sectional analysis. Annals of Medicine and Surgery, 2020. 60: p. 44-49.

Chang, Y.-K., Y.-T. Tseng, and K.-T. Chen, The epidemiologic characteristics and associated risk factors of preterm birth from 2004 to 2013 in Taiwan. BMC pregnancy and childbirth, 2020. 20: p. 1-7.

Romero, R., et al., The preterm parturition syndrome. BJOG: An International Journal of Obstetrics & Gynaecology, 2006. 113: p. 17-42.

Goldenberg, R.L., et al., Epidemiology and causes of preterm birth. The lancet, 2008. 371(9606): p. 75-84.

Romero, R., et al., Intraamniotic infection and the onset of labor in preterm premature rupture of the membranes. American journal of obstetrics and gynecology, 1988. 159(3): p. 661-666.

Hörauf, J.-A., et al., Motor vehicle accident during pregnancy with two lifes at risk: A case report. Journal of orthopaedic case reports, 2021. 11(7): p. 65.

Salim, R., et al., Double‐blind randomized trial of progesterone to prevent preterm birth in second‐trimester bleeding. Acta Obstetricia et Gynecologica Scandinavica, 2019. 98(10): p. 1318-1325.

van Zijl, M.D., et al., Pessary or Progesterone to Prevent Preterm delivery in women with short cervical length: the Quadruple P randomised controlled trial. BMC pregnancy and childbirth, 2017. 17(1): p. 1-8.

Romero, R., et al., Vaginal progesterone in women with an asymptomatic sonographic short cervix in the midtrimester decreases preterm delivery and neonatal morbidity: a systematic review and metaanalysis of individual patient data. American journal of obstetrics and gynecology, 2012. 206(2): p. 124. e1-124. e19.

Alfirevic, Z., et al., Vaginal progesterone, cerclage or cervical pessary for preventing preterm birth in asymptomatic singleton pregnant women with a history of preterm birth and a sonographic short cervix. Ultrasound in obstetrics & gynecology, 2013. 41(2): p. 146-151.

da Fonseca, E.B., R. Damião, and D.A. Moreira, Preterm birth prevention. Best Practice & Research Clinical Obstetrics & Gynaecology, 2020. 69: p. 40-49.

Hezelgrave, N.L., et al., Rationale and design of SuPPoRT: a multi-centre randomised controlled trial to compare three treatments: cervical cerclage, cervical pessary and vaginal progesterone, for the prevention of preterm birth in women who develop a short cervix. BMC pregnancy and childbirth, 2016. 16: p. 1-10.

Norman, J.E., Progesterone and preterm birth. International Journal of Gynecology & Obstetrics, 2020. 150(1): p. 24-30.

Karbasian, N., et al., Combined treatment with cervical pessary and vaginal progesterone for the prevention of preterm birth: a randomized clinical trial. Journal of Obstetrics and Gynaecology Research, 2016. 42(12): p. 1673-1679.

Norman, J.E., et al., Vaginal progesterone prophylaxis for preterm birth (the OPPTIMUM study): a multicentre, randomised, double-blind trial. The lancet, 2016. 387(10033): p. 2106-2116.

Jarde, A., et al., Vaginal progesterone, oral progesterone, 17‐OHPC, cerclage, and pessary for preventing preterm birth in at‐risk singleton pregnancies: an updated systematic review and network meta‐analysis. BJOG: An International Journal of Obstetrics & Gynaecology, 2019. 126(5): p. 556-567.

Care, A., et al., Cervical cerclage, pessary, or vaginal progesterone in high-risk pregnant women with short cervix: a randomized feasibility study. The Journal of Maternal-Fetal & Neonatal Medicine, 2021. 34(1): p. 49-57.

Coomarasamy, A., et al., A randomized trial of progesterone in women with recurrent miscarriages. New England Journal of Medicine, 2015. 373(22): p. 2141-2148.

Saccone, G., et al., Vaginal progesterone vs intramuscular 17α‐hydroxyprogesterone caproate for prevention of recurrent spontaneous preterm birth in singleton gestations: systematic review and meta‐analysis of randomized controlled trials. Ultrasound in Obstetrics & Gynecology, 2017. 49(3): p. 315-321.

López-Romero, L., E. Romero, and M.A. Luengo, Disentangling the role of psychopathic traits and externalizing behaviour in predicting conduct problems from childhood to adolescence. Journal of Youth and Adolescence, 2012. 41(11): p. 1397-1408.

Kuon, R.-J., et al., Progesteron zur Prävention der Frühgeburt–Evidenz-basierte Indikationen. Zeitschrift für Geburtshilfe und Neonatologie, 2015. 219(03): p. 125-135.

Goepfert, A.R., Management Strategies to Prevent Preterm Birth Preface. 2012, WB SAUNDERS CO-ELSEVIER INC 1600 JOHN F KENNEDY BOULEVARD, STE 1800 …. p. XIII-XV.

Azargoon, A., R. Ghorbani, and F. Aslebahar, Vaginal progesterone on the prevention of preterm birth and neonatal complications in high risk women: a randomized placebo-controlled double-blind study. International journal of reproductive biomedicine, 2016. 14(5): p. 309.




How to Cite

Saman Ejaz, Maryam Raana, Muhammad Essa, Sadaf Zahra, Snovia Ishaq, Uswa Shoaib, … Zain Ul Abideen. (2024). Comparing Prophylactic Vaginal Progesterone & Cervical Cerclage In Preventing Preterm Birth: A Systematic Review. BioSight, 5(1), 1–10.




Most read articles by the same author(s)